Shares of Solventum Co. (NYSE:SOLV – Get Free Report) have earned a consensus rating of “Hold” from the eleven ratings firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $79.86.
SOLV has been the topic of several research analyst reports. Wells Fargo & Company raised their price target on shares of Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. Piper Sandler lifted their target price on Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a research report on Friday, February 28th. Bank of America upped their price target on Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a report on Wednesday, February 26th. Morgan Stanley lifted their price objective on Solventum from $73.00 to $80.00 and gave the stock an “equal weight” rating in a report on Wednesday, March 5th. Finally, Mizuho upped their target price on Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a research note on Monday, March 3rd.
Read Our Latest Stock Report on Solventum
Institutional Inflows and Outflows
Solventum Stock Up 0.9 %
SOLV opened at $74.87 on Wednesday. The business has a 50 day moving average of $75.38 and a 200-day moving average of $71.73. The stock has a market capitalization of $12.95 billion and a price-to-earnings ratio of 27.23. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. Solventum has a 1-year low of $47.16 and a 1-year high of $85.92.
About Solventum
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Featured Stories
- Five stocks we like better than Solventum
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Quiet Period Expirations Explained
- NVIDIA Insiders Sell: This Is What It Means for the Market
- What is a penny stock? A comprehensive guide
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.